You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Pre-Exposure Prophylaxis of HIV Infection Trial (Lenacapavir Injection, Lenacapavir Tablet, Emtricitabine/tenofovir disoproxil

Not yet recruiting
  • Pre-Exposure Prophylaxis of HIV Infection
  • Lenacapavir Injection
  • +2 more
  • (no location specified)
Oct 20, 2023

Pre-Exposure Prophylaxis of HIV Infection Trial (Lenacapavir Tablet, Lenacapavir Injection, Emtricitabine/Tenofovir Disoproxil

Not yet recruiting
  • Pre-Exposure Prophylaxis of HIV Infection
  • Lenacapavir Tablet
  • +2 more
  • (no location specified)
Oct 20, 2023

Bone Mineral Density Substudy - An Ancillary Study to MTN-003

Completed
  • HIV Infections
  • Emtricitabine/tenofovir disoproxil fumarate
  • +3 more
  • Kampala, Uganda
  • +3 more
Oct 28, 2021

HIV Trial (Tenofovir disoproxil fumarate/emtricitabine (TDF-FTC), cabotegravir (CAB-LA), Cabotegravir (CAB-LA), Tenofovir

Not yet recruiting
  • HIV
  • Tenofovir disoproxil fumarate/emtricitabine (TDF-FTC), cabotegravir (CAB-LA)
  • Cabotegravir (CAB-LA), Tenofovir disoproxil fumarate/emtricitabine (TDF-FTC)
  • (no location specified)
Nov 13, 2023

Acceptability of Health Care, Adherence, Medication Trial in Durban, Pietermaritzburg, Harare (emtricitabine/tenofovir

Recruiting
  • Acceptability of Health Care
  • Adherence, Medication
  • emtricitabine/tenofovir alafenamide
  • Emtricitabine / Tenofovir Disoproxil Oral Tablet
  • Durban, KZN, South Africa
  • +2 more
Jul 12, 2022

Drug Interaction Trial in Bangkok (Emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg (F/TDF) and emtricitabine 200

Recruiting
  • Drug Interaction
  • Emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg (F/TDF) and emtricitabine 200 mg/tenofovir alafenamide 25 mg (F/TAF)
  • Bangkok, Pathumwan, Thailand
    Institute of HIV Research and Innovation (IHRI)
Apr 21, 2022

Pregnancy, HIV-1-infection Trial (Standard dose Truvada®, Pregnancy-adjusted dose Truvada®)

Withdrawn
  • Pregnancy
  • HIV-1-infection
  • Standard dose Truvada®
  • Pregnancy-adjusted dose Truvada®
  • (no location specified)
Mar 28, 2022

HIV-1/HBV Co-Infection Trial in Worldwide (B/F/TAF, Placebo to match DTG, Placebo to match F/TDF)

Active, not recruiting
  • HIV-1/HBV Co-Infection
  • Fort Pierce, Florida
  • +66 more
Sep 19, 2022

HIV/AIDS, Adherence, Medication, Drug Use Trial in Norfolk (Tenofovir Disoproxil Fumarate)

Completed
  • HIV/AIDS
  • +2 more
  • Tenofovir Disoproxil Fumarate
  • Norfolk, Virginia
    Clinical Research Center, Eastern Virginia Medical School
Apr 12, 2022

HIV Trial in Worldwide (Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF), Behavioral HIV risk reduction package)

Recruiting
  • HIV Infections
  • Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF)
  • Behavioral HIV risk reduction package
  • Blantyre, Malawi
  • +6 more
Jun 20, 2022

HIV Trial in Johannesburg, Kampala, Chitungwiza (Dapivirine (DPV) Vaginal Ring (VR)-004, Truvada Tablet)

Completed
  • HIV Infections
  • Dapivirine (DPV) Vaginal Ring (VR)-004
  • Truvada Tablet
  • Blantyre, Malawi
  • +3 more
Nov 17, 2022

HIV-1-infection Trial in Edmonton (B/F/TAF, Atripla, B/F/TAF Placebo)

Terminated
Has Results
  • HIV-1-infection
  • Edmonton, Alberta, Canada
    University of Alberta
Nov 21, 2022

HIV-1-infection Trial in Shanghai, Kunming, Hangzhou (B/F/TAF, TDF-based triple ART regimen switching to B/F/TAF)

Recruiting
  • HIV-1-infection
  • B/F/TAF
  • TDF-based triple ART regimen switching to B/F/TAF
  • Shanghai, Shanghai, China
  • +2 more
Dec 1, 2022

Aicardi Goutières Syndrome Trial in Philadelphia (Tenofovir (TDF) and Emtricitabine (FTC), Placebo)

Not yet recruiting
  • Aicardi Goutières Syndrome
  • Tenofovir (TDF) and Emtricitabine (FTC)
  • Placebo
  • Philadelphia, Pennsylvania
    Children's Hospital of Philadelphia
Feb 8, 2022

HIV Pre-exposure Prophylaxis During Breastfeeding Trial in Thika, Kampala (FTC/TDF PrEP)

Completed
  • HIV Pre-exposure Prophylaxis During Breastfeeding
  • FTC/TDF PrEP
  • Thika, Kenya
  • +1 more
Sep 14, 2021

Drug Interaction Trial in Montréal (ATI-2173 50 mg, Tenofovir 300Mg Oral Tablet)

Completed
  • Drug Interaction
  • ATI-2173 50 mg
  • Tenofovir 300Mg Oral Tablet
  • Montréal, Quebec, Canada
    Altasciences
Feb 3, 2022

HIV Trial in Puerto Rico, United States (Emtricitabine, Enfuvirtide, Ritonavir)

Completed
  • HIV Infections
  • Aurora, Colorado
  • +6 more
Oct 28, 2021

HIV Trial in Johannesburg, Kampala, Chitungwiza (Dapivirine (DPV) Vaginal Ring (VR), Truvada Tablet)

Active, not recruiting
  • HIV Infections
  • Dapivirine (DPV) Vaginal Ring (VR)
  • Truvada Tablet
  • Blantyre, Malawi
  • +3 more
Feb 1, 2023

HIV Trial in Johannesburg (Cabotegravir Injection [Apretude], Tenofovir disoproxil fumarate / emtricitabine (or lamivudine))

Not yet recruiting
  • HIV Infections
  • Cabotegravir Injection [Apretude]
  • Tenofovir disoproxil fumarate / emtricitabine (or lamivudine)
  • Johannesburg, Gauteng, South Africa
    Ezintsha, a division of Wits Health Consortium
Nov 13, 2023

Hepatitis B, Chronic, Hepatitis D Trial in Chisinau, Kyiv (ATI-2173, Viread, AB-729)

Terminated
  • Hepatitis B, Chronic
  • Hepatitis D
  • Chisinau, Republic Of Moldova, Moldova, Republic of
  • +1 more
Nov 15, 2022

HIV Trial (Tenofovir Disoproxil Fumarate 300 mg + Emtricitabine 200 mg)

Completed
Has Results
  • HIV Infections
  • Tenofovir Disoproxil Fumarate 300 mg + Emtricitabine 200 mg
  • (no location specified)
May 11, 2022

Multiple Sclerosis Trial in Boston (Truvada (tenofovir/emtricitabine))

Enrolling by invitation
  • Multiple Sclerosis
  • Truvada (tenofovir/emtricitabine)
  • Boston, Massachusetts
    Massachusetts General Hospital
Jul 14, 2023

Antiretroviral Adherence and Drug-level Monitoring

Recruiting
  • HIV Infections
  • +4 more
    • Surabaya, East Java, Indonesia
      Universitas Airlangga Hospital
    Aug 17, 2023

    HIV-I, Human Immunodeficiency Virus Type 1, Prophylaxis Trial in South Africa, Uganda, United States (Islatravir, Placebo to

    Active, not recruiting
    • HIV-I
    • +2 more
    • Birmingham, Alabama
    • +23 more
    Aug 15, 2022

    Medication Adherence, HIV Trial in Pittsburgh (dolutegravir oral tablet 50mg, emtricitabine/tenofovir alafenamide oral tablet

    Completed
    • Medication Adherence
    • HIV
    • dolutegravir oral tablet 50mg
    • +3 more
    • Pittsburgh, Pennsylvania
      HIV/AIDS Clinical Research Unit / University of Pittsburgh
    Mar 2, 2022